Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 3
2006 3
2007 2
2008 5
2009 3
2010 1
2011 1
2012 1
2013 1
2014 2
2015 7
2016 13
2017 9
2018 4
2019 9
2020 14
2021 13
2022 8
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Radiation dose-volume effects in the larynx and pharynx.
Rancati T, Schwarz M, Allen AM, Feng F, Popovtzer A, Mittal B, Eisbruch A. Rancati T, et al. Among authors: popovtzer a. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S64-9. doi: 10.1016/j.ijrobp.2009.03.079. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171520 Free PMC article. Review.
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
Averbuch I, Salman S, Shtamper N, Doweck I, Popovtzer A, Markel G, Hendler D, Finkel I, Moore A, Fenig E, Taha T, Mhameed K, Kurman N, Billan S. Averbuch I, et al. Among authors: popovtzer a. Front Oncol. 2023 Jan 26;13:1117804. doi: 10.3389/fonc.2023.1117804. eCollection 2023. Front Oncol. 2023. PMID: 36793605 Free PMC article.
Patterns of metastases progression- The linear parallel ratio.
Gofrit ON, Gofrit B, Roditi Y, Popovtzer A, Frank S, Sosna J, Goldberg SN. Gofrit ON, et al. Among authors: popovtzer a. PLoS One. 2022 Sep 21;17(9):e0274942. doi: 10.1371/journal.pone.0274942. eCollection 2022. PLoS One. 2022. PMID: 36129954 Free PMC article.
Cetuximab intensifies cisplatin-induced testicular toxicity.
Levi M, Popovtzer A, Tzabari M, Mizrachi A, Savion N, Stemmer SM, Shalgi R, Ben-Aharon I. Levi M, et al. Among authors: popovtzer a. Reprod Biomed Online. 2016 Jul;33(1):102-10. doi: 10.1016/j.rbmo.2016.04.004. Epub 2016 Apr 20. Reprod Biomed Online. 2016. PMID: 27184186
An urgent call for the immediate release of Israeli hostages.
Paluch-Shimon S, Popovtzer A, Leibowitz R. Paluch-Shimon S, et al. Among authors: popovtzer a. Lancet. 2023 Oct 28;402(10412):1521. doi: 10.1016/S0140-6736(23)02288-2. Epub 2023 Oct 13. Lancet. 2023. PMID: 37844591 No abstract available.
103 results